User:Mr. Ibrahem/Sertaconazole
 | |
 | |
| Clinical data | |
|---|---|
| Trade names | Ertaczo, Dermofix, Zalain |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a608047 |
| License data |
|
| Routes of administration | Topical |
| Drug class | Azole[1] |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | Negligible |
| Protein binding | >99% to plasma |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C20H15Cl3N2OS |
| Molar mass | 437.76 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Sertaconazole, sold under the brand name Ertaczo among others, is an antifungal medication used to treat athlete's foot, ringworm, pityriasis versicolor, and candidiasis of the skin.[1] It is applied to the area of infection twice per day for 4 weeks.[1]
Common side effects include dry skin, burning skin, and inflamed skin.[1] Allergic reactions may occur.[1] It is in the azole class of medication.[1]
Sertaconazole was approved for medical use in the United States in 2003.[1] In the United States a 60 gram tube costs about 830 USD as of 2021.[2] This makes it significantly more expensive than generic and over the counter options.[3]
References[edit]
- ^ a b c d e f g h i "Sertaconazole Monograph for Professionals". Drugs.com. Archived from the original on 24 January 2021. Retrieved 12 October 2021.
- ^ "Ertaczo Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 7 November 2016. Retrieved 12 October 2021.
- ^ Onion, Daniel K.; Glazer, James (25 October 2010). The Little Black Book of Primary Care. Jones & Bartlett Publishers. p. 107. ISBN 978-1-4496-7197-6. Archived from the original on 12 October 2021. Retrieved 12 October 2021.